Basic Information
Basic information for SOX9-AS1-239-16aa-2
Peptide Name SOX9-AS1-239-16aa-2
Genome Position chr17:72083906-72083949,72085042-72085045[-]
Species Human
Peptide Sequence MVWPWRHGIRNIPQRS
Peptide Length 16
Unique No (SOX9-AS1-204-16aa-1,SOX9-AS1-210-16aa,SOX9-AS1-213-16aa-1,SOX9-AS1-216-16aa-2,SOX9-AS1-218-16aa,SOX9-AS1-221-16aa,SOX9-AS1-224-16aa,SOX9-AS1-225-16aa-1,SOX9-AS1-229-16aa-1,SOX9-AS1-230-16aa-2,SOX9-AS1-231-16aa-1,SOX9-AS1-232-16aa-2,SOX9-AS1-233-16aa-2,SOX9-AS1-234-16aa-2,SOX9-AS1-235-16aa,SOX9-AS1-236-16aa,SOX9-AS1-238-16aa)
Grand Average of Hydropathicity -0.925
Relative Molecular Mass 2303.59
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000671151;SOX9-AS1-239
Transcript Length 1258
Coding Ability 0.6407
DNA Sequence Corresponding to Peptide ATGGTCTGGCCATGGAGGCATGGTATCCGTAACATCCCCCAAAGGAGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :